Literature DB >> 2674202

Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy.

V Del Bono1, A Canessa, P Bruzzi, M A Fiorelli, A Terragna.   

Abstract

The persistence of immunoglobulin M (IgM) antibody to Toxoplasma gondii in sera from 38 patients after toxoplasmic lymphadenopathy was investigated by using an indirect immunofluorescence assay, a double-sandwich enzyme-linked immunosorbent assay, and an immunosorbent agglutination assay. Positive predictive values at 3 and 6 months after lymphadenopathy were, respectively, 45 and 73% for the indirect immunofluorescence assay, 25 and 45% for the double-sandwich enzyme-linked immunosorbent assay, and 22 and 43% for the immunosorbent agglutination assay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674202      PMCID: PMC267759          DOI: 10.1128/jcm.27.9.2133-2135.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration.

Authors:  J S Remington; M J Miller; I Brownlee
Journal:  Pediatrics       Date:  1968-06       Impact factor: 7.124

2.  Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii.

Authors:  P Herbrink; A M van Loon; J P Rotmans; F van Knapen; W C van Dijk
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

3.  Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water.

Authors:  M W Benenson; E T Takafuji; S M Lemon; R L Greenup; A J Sulzer
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

4.  Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence.

Authors:  N Pyndiah; U Krech; P Price; J Wilhelm
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

5.  Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Authors:  F Wielaard; H van Gruijthuijsen; W Duermeyer; A W Joss; L Skinner; H Williams; E H van Elven
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis.

Authors:  B J Luft; G Kansas; E G Engleman; J S Remington
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

7.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

8.  Diagnostic significance of immunoglobulin M antibodies to Toxoplasma gondii detected after separation of immunoglobulin M from immunoglobulin G antibodies.

Authors:  G A Filice; A S Yeager; J S Remington
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections.

Authors:  G Desmonts; Y Naot; J S Remington
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

  9 in total
  21 in total

1.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis.

Authors:  O Liesenfeld; C Press; R Flanders; R Ramirez; J S Remington
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies.

Authors:  E Candolfi; R Ramirez; M P Hadju; C Shubert; J S Remington
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

4.  Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.

Authors:  Reshika Dhakal; Kiran Gajurel; Christelle Pomares; Jeanne Talucod; Cynthia J Press; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

5.  Evaluation of immunoblotting for the detection of Toxoplasma gondii immunoglobulin M antibodies.

Authors:  C Verhofstede; L Van Renterghem; J Plum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

6.  Recognition of recombinant Toxoplasma gondii antigens by human sera in an ELISA.

Authors:  A M Tenter; A M Johnson
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

7.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

8.  Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients.

Authors:  A Canessa; V Del Bono; P De Leo; N Piersantelli; A Terragna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

9.  Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis.

Authors:  S Y Wong; M P Hajdu; R Ramirez; P Thulliez; R McLeod; J S Remington
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Multicenter evaluation of a new commercial assay for detection of immunoglobulin M antibodies to Toxoplasma gondii. Multicenter Study Group.

Authors:  V Luyasu; A R Robert; L Schaefer; J Macioszek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.